Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human
- DOI
- 10.1007/s00213-025-06861-4
- Published
- 2025-08-11
- Container
- Psychopharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00213-025-06861-4,
title = {Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human},
author = {Lieuwe Appel and Robert Risinger and Anders Wall and Harald Murck and Shuang Liu and Gunnar Antoni and Roger Lane},
year = {2025},
journal = {Psychopharmacology},
doi = {10.1007/s00213-025-06861-4},
url = {https://doi.org/10.1007/s00213-025-06861-4}
}RIS
TY - JOUR TI - Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human AU - Lieuwe Appel AU - Robert Risinger AU - Anders Wall AU - Harald Murck AU - Shuang Liu AU - Gunnar Antoni AU - Roger Lane PY - 2025 JO - Psychopharmacology DO - 10.1007/s00213-025-06861-4 UR - https://doi.org/10.1007/s00213-025-06861-4 ER -
APA
Appel, L., Risinger, R., Wall, A., Murck, H., Liu, S., Antoni, G., & Lane, R. (2025). Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human. Psychopharmacology. https://doi.org/10.1007/s00213-025-06861-4
Source records
- crossref · retrieved 2026-09-26T21:03:44.123Z